Immunocytochemical quantification of tyrosine hydroxylase at a cellular level in the mesencephalon of control subjects and patients with Parkinson's and Alzheimer's disease
- PMID: 8103078
- DOI: 10.1111/j.1471-4159.1993.tb03616.x
Immunocytochemical quantification of tyrosine hydroxylase at a cellular level in the mesencephalon of control subjects and patients with Parkinson's and Alzheimer's disease
Abstract
Parkinson's disease is characterized by massive degeneration of the melanized dopaminergic neurons in the substantia nigra. The functional capacity of the surviving nigral neurons is affected, as indicated by the subnormal levels of tyrosine hydroxylase (TH) mRNA in these neurons and the presence in the parkinsonian mesencephalon of melanized neurons lacking TH immunoreactivity. This is apparently in contraction with the known overactivity of dopamine synthesis and release that occurs in the remaining dopaminergic terminals. To test the ability of the surviving neurons to express TH protein, a semiquantitative immunocytochemical method was developed. The relative amounts of TH were estimated with a computer-assisted image analysis system in the dopaminergic neurons of representative mesencephalic sections of control and parkinsonian brains and for comparison in brains from patients with Alzheimer's disease. In control brains, the mean TH content per neuron differed from one subject to another and between the different dopaminergic cell groups of the mesencephalon in the same subject. Within a given dopaminergic region, the level of TH was variable among neurons. In patients with Parkinson's disease, the ratio of TH protein content per neuron in the substantia nigra by reference to that of the central gray substance was reduced. In patients with Alzheimer's disease, the amount of TH was selectively reduced in the remaining dopaminergic neurons of the ventral tegmental area, a region characterized by a loss in dopaminergic neurons. The decrease in cellular TH content might therefore be related to the presence of the neurodegenerative process in the area considered. In patients with Parkinson's disease, the incapacity of the surviving neurons to express normal TH levels may reduce the efficiency of the hyperactivity mechanisms that develop in the remaining striatal dopaminergic terminals.
Similar articles
-
Decreased tyrosine hydroxylase messenger RNA in the surviving dopamine neurons of the substantia nigra in Parkinson's disease: an in situ hybridization study.Neuroscience. 1990;38(1):245-53. doi: 10.1016/0306-4522(90)90389-l. Neuroscience. 1990. PMID: 1979431
-
Differential modification of dopamine transporter and tyrosine hydroxylase mRNAs in midbrain of subjects with Parkinson's, Alzheimer's with parkinsonism, and Alzheimer's disease.Mov Disord. 1997 Nov;12(6):885-97. doi: 10.1002/mds.870120609. Mov Disord. 1997. PMID: 9399211
-
Regional distribution of monoamine vesicular uptake sites in the mesencephalon of control subjects and patients with Parkinson's disease: a postmortem study using tritiated tetrabenazine.Brain Res. 1995 Sep 18;692(1-2):233-43. doi: 10.1016/0006-8993(95)00674-f. Brain Res. 1995. PMID: 8548309
-
Glutamate transport and metabolism in dopaminergic neurons of substantia nigra: implications for the pathogenesis of Parkinson's disease.J Neurol. 2000 Apr;247 Suppl 2:II25-35. doi: 10.1007/pl00007757. J Neurol. 2000. PMID: 10991662 Review.
-
Diversity matters - heterogeneity of dopaminergic neurons in the ventral mesencephalon and its relation to Parkinson's Disease.J Neurochem. 2016 Oct;139 Suppl 1(Suppl Suppl 1):8-26. doi: 10.1111/jnc.13670. Epub 2016 Jun 27. J Neurochem. 2016. PMID: 27206718 Free PMC article. Review.
Cited by
-
Evaluation of α-synuclein and apolipoprotein E as potential biomarkers in cerebrospinal fluid to monitor pharmacotherapeutic efficacy in dopamine dictated disease states of Parkinson's disease and schizophrenia.Neuropsychiatr Dis Treat. 2019 Jul 19;15:2073-2085. doi: 10.2147/NDT.S205550. eCollection 2019. Neuropsychiatr Dis Treat. 2019. PMID: 31410011 Free PMC article.
-
Human tyrosine hydroxylase in Parkinson's disease and in related disorders.J Neural Transm (Vienna). 2019 Apr;126(4):397-409. doi: 10.1007/s00702-018-1903-3. Epub 2018 Jul 11. J Neural Transm (Vienna). 2019. PMID: 29995172 Review.
-
Cytotoxic Effects of Ochratoxin A in Neuro-2a Cells: Role of Oxidative Stress Evidenced by N-acetylcysteine.Front Microbiol. 2016 Aug 2;7:1142. doi: 10.3389/fmicb.2016.01142. eCollection 2016. Front Microbiol. 2016. PMID: 27531992 Free PMC article.
-
Inflammatory neuronal loss in the substantia nigra induced by systemic lipopolysaccharide is prevented by knockout of the P2Y6 receptor in mice.J Neuroinflammation. 2021 Oct 11;18(1):225. doi: 10.1186/s12974-021-02280-2. J Neuroinflammation. 2021. PMID: 34635136 Free PMC article.
-
℮-conome: an automated tissue counting platform of cone photoreceptors for rodent models of retinitis pigmentosa.BMC Ophthalmol. 2011 Dec 20;11:38. doi: 10.1186/1471-2415-11-38. BMC Ophthalmol. 2011. PMID: 22185426 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical